-
公开(公告)号:USD1023290S1
公开(公告)日:2024-04-16
申请号:US29900985
申请日:2023-08-28
Applicant: AMGEN INC.
Designer: Margaux Frances Boyaval , Sigrid Moeslinger , Masamichi Udagawa
Abstract: The file of this patent contains at least one drawing/photograph executed in color. Copies of this patent with color drawing(s)/photograph(s) will be provided by the Office upon request and payment of the necessary fee.
FIG. 1 is a perspective view showing a new design for an autoinjector with a removable cap, showing the removable cap disposed on the autoinjector;
FIG. 2 is a front view of the autoinjector of FIG. 1;
FIG. 3 is a rear view of the autoinjector with removable cap of FIG. 1;
FIG. 4 is a left-side view of the autoinjector with removable cap of FIG. 1;
FIG. 5 is a right-side view of the autoinjector with removable cap of FIG. 1;
FIG. 6 is a top view of the autoinjector with removable cap of FIG. 1;
FIG. 7 is a bottom view of the autoinjector with removable cap of FIG. 1; and,
FIG. 8 is a perspective view showing the autoinjector with removable cap of FIGS. 1-7 with the removable cap removed.-
公开(公告)号:US20210402083A1
公开(公告)日:2021-12-30
申请号:US17386659
申请日:2021-07-28
Applicant: AMGEN INC.
Inventor: Scott R. Gibson , Sheldon B. Moberg , Basel Hasan Taha , Margaux Frances Boyaval , Mark A. Destefano , Lawton Laurence , John C. Love , Ian B. Hanson , Paul F. Bente, IV , Matthew J. Clemente , Antonio Ubach , Rajan Ramaswamy , Daniel S. Codd , Scott Beaver , Kevin L. Bokelman , Ian P. Dardani , Sean M. O'connor , Danielle Feldman
Abstract: Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor (G-CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device may include a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector may define a sterile fluid flowpath between the container and the insertion mechanism. Optionally, a cannula initially disposed about the needle may be included. The cannula may be retained in the patient at an injection site created by the needle after the needle is withdrawn from the patient. Methods of assembly and operation are also provided.
-
公开(公告)号:USD898189S1
公开(公告)日:2020-10-06
申请号:US29723028
申请日:2020-02-04
Applicant: AMGEN INC.
Designer: Margaux Frances Boyaval , Sigrid Moeslinger , Masamichi Udagawa
-
公开(公告)号:USD886281S1
公开(公告)日:2020-06-02
申请号:US29661300
申请日:2018-08-27
Applicant: AMGEN INC.
Designer: Margaux Frances Boyaval , Sigrid Moeslinger , Masamichi Udagawa
-
公开(公告)号:USD878559S1
公开(公告)日:2020-03-17
申请号:US29636584
申请日:2018-02-09
Applicant: AMGEN INC.
Designer: Brian Stonecipher , Peter V. Shultz , Lisa Nugent , Margaux Frances Boyaval , Sigrid Moeslinger , Masamichi Udagawa
-
公开(公告)号:USD838359S1
公开(公告)日:2019-01-15
申请号:US29578427
申请日:2016-09-21
Applicant: AMGEN INC.
Designer: Margaux Frances Boyaval , Sigrid Moeslinger , Lisa Nugent , Brian Stonecipher , Masamichi Udagawa
-
公开(公告)号:USD827128S1
公开(公告)日:2018-08-28
申请号:US29597038
申请日:2017-03-14
Applicant: AMGEN INC.
Designer: Margaux Frances Boyaval , Sigrid Moeslinger , Masamichi Udagawa
-
公开(公告)号:USD814022S1
公开(公告)日:2018-03-27
申请号:US29561893
申请日:2016-04-20
Applicant: AMGEN INC.
Designer: Margaux Frances Boyaval , Sigrid Moeslinger , Masamichi Udagawa
-
公开(公告)号:USD813380S1
公开(公告)日:2018-03-20
申请号:US29573430
申请日:2016-08-05
Applicant: AMGEN INC.
Designer: Brian Stonecipher , Peter V. Shultz , Lisa Nugent , Margaux Frances Boyaval , Sigrid Moeslinger , Masamichi Udagawa
-
公开(公告)号:US20250108172A1
公开(公告)日:2025-04-03
申请号:US18891521
申请日:2024-09-20
Applicant: AMGEN INC.
Inventor: Margaux Frances Boyaval , Brian Stonecipher , Avon Kuo , James Chan , Lisa Nugent
Abstract: Drug delivery devices are described that provide hybrid forms with gripping and stability functionalities, such as a grip portion on a skin contact surface. In some versions, the drug delivery devices can include a cap having a release liner such that removal of the cap exposes the grip portion. In some versions, the drug delivery devices include a retractable needle guard having the grip portion extending therearound.
-
-
-
-
-
-
-
-
-